Turn Therapeutics Inc. (TTRX) stock

TTRXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 2/30

$9.35−0.79 (-7.75%)

Close on Nov 13, 2026Market cap $278.37MP/E –Yield –

Turn Therapeutics ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2025 it was -$5.81M.

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$5.81M	–
FY2024	Dec 31, 2024	-$1.75M	–

See a number that looks wrong?